Celiac Disease

Celiac Disease – High-Yield Study Guide for Medical Students

Definition

Celiac disease is a chronic, immune-mediated enteropathy triggered by dietary gluten (prolamins in wheat, barley, and rye) in genetically susceptible individuals, characterized by small intestinal mucosal inflammation, villous atrophy, and crypt hyperplasia that improve on a strict gluten-free diet. It is classified as an autoimmune disorder with both intestinal and extraintestinal manifestations.^[4]

Epidemiology

Celiac disease occurs worldwide with an estimated prevalence around 1% in many populations, though many cases remain undiagnosed. There is a strong association with other autoimmune diseases, most notably type 1 diabetes mellitus and autoimmune thyroid disease.^[7],[10]

Key epidemiologic points:

• Genetic background: Strong association with HLA-DQ2 and HLA-DQ8 (present in the majority of patients, but also in up to 30–40% of the general population).
• Age: Can present at any age, from infancy after gluten introduction to late adulthood.
• Sex: More common in females.
• High-risk groups: First-degree relatives of affected individuals, patients with type 1 diabetes, autoimmune thyroid disease, Down syndrome, Turner syndrome, and selective IgA deficiency.^[10]

Pathophysiology

The pathophysiology of celiac disease involves a complex interplay between genetic susceptibility, environmental exposure to gluten, and immune dysregulation, resulting in autoimmune-mediated small bowel injury.^[4]

• Gluten antigen: Gliadin and related prolamins are rich in glutamine and proline and are resistant to complete digestion. Partially digested peptides reach the small intestinal mucosa.
• Tissue transglutaminase (tTG): tTG deamidates gliadin peptides, increasing their affinity for HLA-DQ2/DQ8 on antigen-presenting cells.
• Adaptive immune response: Presentation of deamidated gliadin peptides to CD4+ T cells in the lamina propria triggers a Th1-dominant response with production of proinflammatory cytokines (e.g., IFN-γ) and B-cell activation, leading to anti-tTG, anti-endomysial, and anti-deamidated gliadin antibodies.
• Innate immune response: Upregulation of IL-15 and activation of intraepithelial lymphocytes (IELs) promotes epithelial damage.
• Histologic changes: Villous atrophy, crypt hyperplasia, and increased IELs reduce absorptive surface area and lead to malabsorption of nutrients such as iron, folate, calcium, and fat-soluble vitamins.^[4]

Clinical Presentation

Celiac disease has a broad clinical spectrum ranging from classic malabsorptive symptoms to extraintestinal manifestations and asymptomatic (silent) disease. Many patients present with non-classic features, especially in adulthood.^[4]

Classic (Gastrointestinal) Manifestations

• Chronic diarrhea: Often bulky, foul-smelling, greasy (steatorrhea) stools due to fat malabsorption.
• Weight loss and failure to thrive: Especially in children; may also see irritability and abdominal distension.
• Abdominal pain and bloating and excessive flatulence.
• Anorexia or early satiety in some patients.

Extraintestinal Manifestations

• Iron-deficiency anemia: Often refractory to oral iron due to impaired duodenal absorption.
• Osteopenia/osteoporosis and fractures: Due to calcium and vitamin D malabsorption and secondary hyperparathyroidism.
• Short stature or delayed puberty in children.
• Fatigue and malaise related to anemia and systemic inflammation.
• Neurologic manifestations: Peripheral neuropathy, ataxia, headaches, and rarely epilepsy.
• Dermatologic: Dermatitis herpetiformis (pruritic papulovesicular rash on extensor surfaces, scalp, buttocks), a specific cutaneous manifestation of gluten sensitivity.
• Reproductive: Infertility, recurrent miscarriages, menstrual irregularities.
• Oral manifestations: Recurrent aphthous ulcers and enamel defects; oral lesions are recognized as manifestations of systemic disease and may be clues in dental settings.^[9]

Associated Autoimmune and Systemic Conditions

• Type 1 diabetes mellitus: Coexistence is common (~6% in T1D cohorts), and celiac disease can complicate glycemic control by altering nutrient absorption and dietary patterns.^[7]
• Autoimmune thyroid disease: Higher prevalence of Hashimoto thyroiditis and Graves disease in celiac patients and vice versa.^[10]
• Other associations: Autoimmune hepatitis, primary biliary cholangitis, Addison disease, autoimmune polyendocrine syndromes, selective IgA deficiency, and possibly other autoimmune gastrointestinal disorders.^[2],[3]
• Cardiovascular disease: Meta-analyses show a modest but significant association between celiac disease and various cardiovascular outcomes, potentially mediated by chronic inflammation and nutritional deficiencies.^[5]

Diagnosis

Diagnosis relies on a combination of serologic tests, small intestinal biopsy, and response to a gluten-free diet. Importantly, testing should be performed while the patient is on a gluten-containing diet.

Initial Evaluation

• Clinical suspicion: Unexplained iron-deficiency anemia, chronic diarrhea, weight loss, bloating, recurrent oral ulcers, osteoporosis, and associated autoimmune diseases should prompt evaluation.^[4]
• Basic labs: CBC (may show microcytic anemia), ferritin and iron studies, folate and vitamin B12, CMP, calcium, phosphate, vitamin D, coagulation profile (prolonged PT with vitamin K deficiency).

Serologic Testing

• tTG-IgA (tissue transglutaminase IgA): First-line screening test; high sensitivity and specificity in patients with normal IgA levels.
• Total IgA level: Should be checked concurrently to exclude IgA deficiency, which can cause false-negative tTG-IgA results.
• Alternative tests in IgA deficiency: tTG-IgG or deamidated gliadin peptide (DGP) IgG.
• EMA (endomysial antibodies, IgA): Very specific but more operator-dependent and expensive; often used for confirmation.

In pediatrics, some guidelines allow a no-biopsy diagnosis in selected cases with high tTG-IgA titers (e.g., >10× ULN), positive EMA, compatible symptoms, and HLA-DQ2/DQ8 positivity; however, practice varies by region and guideline.

Endoscopy and Histology

• Upper endoscopy with small bowel biopsy (usually duodenum and duodenal bulb) remains the diagnostic gold standard in adults.
• Typical endoscopic findings: Scalloping of folds, mosaic pattern, reduction or absence of folds, and visible fissures; however, endoscopy may appear normal despite significant histologic disease.
• Histologic changes (Marsh-Oberhuber classification):

• Marsh 0: Normal mucosa.
• Marsh 1: Increased intraepithelial lymphocytes (IELs).
• Marsh 2: IELs plus crypt hyperplasia.
• Marsh 3a–c: Villous atrophy (partial to total) with crypt hyperplasia and increased IELs.

Additional Tests

• HLA typing (HLA-DQ2/DQ8): High negative predictive value; absence makes celiac disease very unlikely. Useful in equivocal or treated cases (e.g., patients who started gluten-free diet prior to testing).
• Screening in associated diseases: Regular screening is recommended in type 1 diabetes and autoimmune thyroid disease due to increased prevalence and impact on metabolic control.^[7],[10]

Management

The cornerstone of management is lifelong strict gluten-free diet (GFD), combined with nutritional optimization, management of complications, and long-term follow-up.^[1],[4]

Gluten-Free Diet

• Eliminate: Wheat (including spelt, kamut), barley, and rye; most conventional breads, pastas, cereals, and many processed foods.
• Allowed grains: Rice, corn (maize), quinoa, buckwheat, amaranth, millet, sorghum, and certified gluten-free oats (oats themselves are gluten-free but often contaminated).
• Cross-contamination avoidance: Separate cooking utensils, toasters, cutting boards; careful label reading and awareness of hidden gluten in sauces, soups, medications, and supplements.
• Dietitian involvement: Specialized dietetic counseling is crucial to ensure adequate caloric and micronutrient intake, especially in students and young adults, who often struggle with adherence in institutional settings.^[6]

Nutritional Assessment and Supplementation

• Baseline and follow-up assessment of iron, folate, vitamin B12, calcium, vitamin D, zinc, and vitamin K.
• Supplement deficiencies: Oral iron, folate, vitamin B12, calcium and vitamin D, and others as needed until levels normalize.
• Bone health: DEXA scan at diagnosis or shortly thereafter in adults (especially in those with risk factors) and repeat per guidelines to monitor osteopenia/osteoporosis.

Monitoring and Follow-Up

• Clinical response: GI symptoms often improve within weeks; complete mucosal healing can take months to years, especially in adults.
• Serology: Repeat tTG-IgA (or appropriate alternative) at 6–12 months after starting GFD and then periodically to assess adherence and mucosal healing.
• Dietary adherence assessment: Regular follow-up with a dietitian; reinforce reading labels, managing eating out, and navigating school or workplace dining options.^[6]
• Vaccination: Consider pneumococcal vaccination in hyposplenic/asplenic patients and standard vaccination review as per general population guidelines.

Management of Non-Responsive and Refractory Celiac Disease

• Non-responsive celiac disease (NRCD): Persistent or recurrent symptoms and/or abnormal serology or histology despite ≥6–12 months on GFD.
• First step: Review diet in detail to identify inadvertent gluten exposure.
• Evaluate for alternative diagnoses: Lactose intolerance, SIBO, IBS, microscopic colitis, pancreatic insufficiency, and other malabsorptive conditions.^[3]
• Refractory celiac disease (RCD): Persistent villous atrophy and symptoms despite strict GFD and exclusion of other causes. Requires subspecialty management and evaluation for clonal IEL populations and risk of enteropathy-associated T-cell lymphoma (EATL).

Special Populations and Settings

• Students and young adults: College and university environments pose challenges for maintaining a strict GFD due to limited safe options, cross-contamination, and social pressures; institutional policies and accommodations (labeling, dedicated gluten-free stations) significantly improve adherence and quality of life.^[1],[6]
• Patients with type 1 diabetes: Coordinated care between gastroenterology, endocrinology, and dietetics is needed to integrate GFD with carbohydrate counting and insulin dosing, as celiac disease may be associated with more frequent uncontrolled HbA1c in some cohorts.^[7]
• Primary care and screening: Increased recognition of nutritional deficiencies and subtle presentations is essential; studies highlight gaps in knowledge among healthcare providers, reinforcing the need for education on celiac-associated micronutrient deficiencies (iron, folate, vitamin D) and long-term risks.^[4]

Complications and Prognosis

• Malnutrition and micronutrient deficiencies: Iron, folate, vitamin B12, calcium, vitamin D, zinc, and others, leading to anemia, osteopenia/osteoporosis, neuropathy, and coagulopathy.
• Skeletal complications: Osteoporosis and fragility fractures due to chronic malabsorption and vitamin D deficiency.
• Reproductive issues: Infertility and adverse pregnancy outcomes improve after initiating GFD.
• Malignancies: Increased risk of enteropathy-associated T-cell lymphoma (EATL), small intestinal adenocarcinoma, and possibly other GI lymphomas; strict adherence to GFD reduces but does not eliminate risk.
• Other autoimmune diseases: Coexistence can worsen overall morbidity; ongoing surveillance and multidisciplinary management are important.^[10]
• Cardiovascular disease: Meta-analytic data suggest an elevated risk of cardiovascular events in some cohorts; mechanisms may include chronic inflammation, nutritional imbalances, and altered lipid profiles.^[5]

With early diagnosis and strict lifelong adherence to a GFD, most patients achieve normalization of serology, mucosal healing, and a prognosis approaching that of the general population.

Key Clinical Pearls for Exams and Practice

• Think beyond diarrhea: Iron-deficiency anemia, osteoporosis, recurrent aphthous ulcers, elevated transaminases, infertility, or neuropathy can all be presenting features.
• Always test before treating: Serology and biopsy must be obtained while the patient is still consuming gluten; do not start a GFD before diagnostic workup.
• First-line screening test: tTG-IgA with total IgA level; consider IgG-based tests in IgA deficiency.
• Associated autoimmunity: Screen patients with type 1 diabetes and autoimmune thyroid disease; likewise, consider thyroid and diabetes screening in new celiac diagnoses.^[7],[10]
• Dermatitis herpetiformis is celiac disease of the skin: Diagnosis can be made by skin biopsy with granular IgA deposits; treatment is GFD (often plus dapsone initially).
• Non-responsive disease: Most often due to ongoing gluten exposure; perform a meticulous dietary review before labeling as refractory.
• Education and environment matter: Institutional support (e.g., in universities) and provider awareness significantly impact adherence and nutritional status.^[1],[4]
• Exam tip: A child with chronic diarrhea, abdominal distension, failure to thrive, and positive tTG-IgA, or an adult with unexplained iron-deficiency anemia and osteoporosis, should trigger consideration of celiac disease.